# Pappas Ventures: portfolio, investments and team

> Pappas Ventures is a vc firm based in United States. 42 investments on record, latest Aug 2016. Portfolio, stages, co-investors and team.

Source: https://millionrounds.com/fund/pappas-ventures (Millionrounds; every figure on the page links to its filing or article)

United States · [Investor](https://millionrounds.com/investors)

# Pappas Ventures

Last cheque observed Aug 2016. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

Quiet VC firm Now at pappas-capital.com

Series A Series B Series C B2B Stock Exchanges Life Science

Cheques on record

**0%** of best year **0** **cheques in 12 months**, 42 on record

Since the last cheque **3723** days **00** hrs **00** min **00** sec

Median round **$16M** Rounds led **0 of 42** Exits **6 from the portfolio** Mostly in **United States, 90%**

Pitch Pappas Ventures

## Pappas Ventures highlights

- 01 42 rounds on record
- 02 Mostly Series A and Series B: 50% of its rounds
- 03 6 exits from the portfolio

## What they do

- **Type:** VC firm (from a list, unverified)
- **Cheque size:** Not stated
- **Sectors:** B2B Stock Exchanges Life Science
- **Based in:** United States
- **Cold pitches:** Not stated

## The record

Every round we can evidence, newest first **42 appearances**

- **2016** 2 rounds
- **Aug** **[Rotation Medical](https://millionrounds.com/company/rotation-medical)** Series B · US · FinSMEs **$12M** With 1 other
- **Feb** **[AgTech Accelerator](https://millionrounds.com/company/agtech-accelerator)** **$20M** With 9 others
- **2015** 3 rounds
- **Jun** **[Milestone Pharmaceuticals](https://millionrounds.com/company/milestone-pharmaceuticals)** Series B · CA **$17M** With 5 others
- **Mar** **[Balance Therapeutics](https://millionrounds.com/company/balance-therapeutics)** Series A · US **$18M** With 2 others
- **Jan** **[CoLucid Pharmaceuticals](https://millionrounds.com/company/colucid-pharmaceuticals)** Series C · US **$37M** With 7 others
- **2014** 2 rounds
- **Jul** **[Rotation Medical](https://millionrounds.com/company/rotation-medical)** Series B · US **$27M** With 2 others
- **Mar** **[Lumena Pharmaceuticals](https://millionrounds.com/company/lumena-pharmaceuticals)** Series B · US **$45M** With 6 others
- **2013** 4 rounds
- **Nov** **[Envisia Therapeutics](https://millionrounds.com/company/envisia-therapeutics)** Series A · US · ca.finance.yahoo.com **$25M** With 4 others
- **Nov** **[Research Triangle Park (RTP)](https://millionrounds.com/company/research-triangle-park-rtp)** Series A · US · fiercebiotech.com **$25M** With 3 others
- **May** **[Lumena Pharmaceuticals](https://millionrounds.com/company/lumena-pharmaceuticals)** Series A · US · reuters.com **$23M** With 2 others
- **Apr** **[Afferent Pharmaceuticals](https://millionrounds.com/company/afferent-pharmaceuticals)** Venture · US **$5.0M** With 1 other
- **2012** 6 rounds
- **Dec** **[Ultragenyx Pharmaceutical](https://millionrounds.com/company/ultragenyx-pharmaceutical)** Growth · US · globenewswire.com **$75M** With 6 others
- **Oct** **[Thrasos](https://millionrounds.com/company/thrasos)** Series C · CA · businesswire.com **$35M** With 6 others
- **Oct** **[CardioDx](https://millionrounds.com/company/cardiodx)** Growth · US **$6.0M** With 3 others
- **Sept** **[IlluminOss Medical](https://millionrounds.com/company/illuminoss-medical)** Series C · US · marketwire.com **$28M** With 8 others
- **Jul** **[CardioDx](https://millionrounds.com/company/cardiodx)** Growth · US **$31M** With 13 others
- **Feb** **[CeNeRx BioPharma](https://millionrounds.com/company/cenerx-biopharma)** Series D · US · onbiovc.com **$4.6M** With 2 others
- **2011** 6 rounds
- **Aug** **[CoLucid Pharmaceuticals](https://millionrounds.com/company/colucid-pharmaceuticals)** Series B · US · prnewswire.com **$7.5M** With 4 others
- **Jun** **[TESARO](https://millionrounds.com/company/tesaro)** Series B · US · finsmes.com **$101M** With 4 others
- **Jun** **[Ultragenyx Pharmaceutical](https://millionrounds.com/company/ultragenyx-pharmaceutical)** Series A · US · finsmes.com **$45M** With 4 others
- **Jun** **[Milestone Pharmaceuticals](https://millionrounds.com/company/milestone-pharmaceuticals)** Venture · CA · money.msn.com **$13M** With 2 others
- **May** **[CardioDx](https://millionrounds.com/company/cardiodx)** Growth · US · finsmes.com **$60M** With 12 others
- **Feb** **[Chimerix](https://millionrounds.com/company/chimerix)** Series F · US · chimerix-inc.com **$45M** With 7 others
- **2010** 7 rounds
- **Dec** **[TyRx Pharma](https://millionrounds.com/company/tyrx-pharma)** Venture · US · tyrx.com **$20M** With 2 others
- **Aug** **[Achillion Pharmaceuticals](https://millionrounds.com/company/achillion-pharmaceuticals)** Venture · US · ir.achillion.com **$50M** With 3 others
- **Aug** **[CeNeRx BioPharma](https://millionrounds.com/company/cenerx-biopharma)** Series C · US · cenerx.com **$13M** With 2 others
- **Jul** **[Liquidia Technologies](https://millionrounds.com/company/liquidia-technologies)** Series C · US · onbiovc.com **$5.0M** With 4 others
- **May** **[CardioDx](https://millionrounds.com/company/cardiodx)** Series D · US · onbiovc.com **$35M** With 7 others
- **Mar** **[Syndax Pharmaceuticals](https://millionrounds.com/company/syndax-pharmaceuticals)** Series A · US · onbiovc.com **$9.0M** With 4 others
- **Jan** **[Liquidia Technologies](https://millionrounds.com/company/liquidia-technologies)** Series C · US · finsmes.com **$20M** With 4 others
- **2009** 3 rounds
- **Dec** **[Afferent Pharmaceuticals](https://millionrounds.com/company/afferent-pharmaceuticals)** Series A · US · finsmes.com **$23M** With 3 others
- **Aug** **[Barosense](https://millionrounds.com/company/barosense)** Series D · US · deals.venturebeat.com **$27M** With 8 others
- **Aug** **[Biosyntech](https://millionrounds.com/company/biosyntech)** Venture · CA · biosyntech.com **$1.4M** With 3 others
- **2008** 3 rounds
- **Aug** **[Anthera Pharmaceuticals](https://millionrounds.com/company/anthera-pharmaceuticals)** Venture · US **$19M** With 5 others
- **Jul** **[CoLucid Pharmaceuticals](https://millionrounds.com/company/colucid-pharmaceuticals)** Series B · US **$25M** With 4 others
- **Mar** **[BrainCells](https://millionrounds.com/company/braincells)** Series B · US · venturebeat.com **$30M** With 5 others
- **2007** 6 rounds
- **Nov** **[LEAD Therapeutics](https://millionrounds.com/company/lead-therapeutics)** Series A · US · leadtherapeutics.com **$17M** With 2 others
- **Oct** **[Optherion](https://millionrounds.com/company/optherion)** Series A · US **$37M** With 6 others
- **Aug** **[FlowCardia](https://millionrounds.com/company/flowcardia)** Series C · US · flowcardia.com **$30M** With 8 others
- **Jun** **[Gentis](https://millionrounds.com/company/gentis)** Series A · US · venturebeat.com **$10M** With 3 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

We hold **7** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## What they claim to have backed

From their own portfolio page (on their website)

**1** of 4 we have independently watched raise

[bio](https://millionrounds.com/company/bio) NVCA Webtoffee nc-biotech

Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.

## Exits from the portfolio

Companies it backed that were later bought or listed **6 in all**

**[Lumena Pharmaceuticals](https://millionrounds.com/company/lumena-pharmaceuticals)** Bought by [Shire](https://millionrounds.com/fund/shire) **$260M** May 2014

**[TyRx Pharma](https://millionrounds.com/company/tyrx-pharma)** Bought by [Medtronic](https://millionrounds.com/fund/medtronic) **$160M** Jan 2014

**[Barosense](https://millionrounds.com/company/barosense)** Bought by [Boston Scientific](https://millionrounds.com/fund/boston-scientific) **Undisclosed** Jul 2013

**[TESARO](https://millionrounds.com/company/tesaro)** Listed **Undisclosed** Mar 2012

**[FlowCardia](https://millionrounds.com/company/flowcardia)** Bought by C. R. Bard **Undisclosed** May 2010

**[Anthera Pharmaceuticals](https://millionrounds.com/company/anthera-pharmaceuticals)** Listed **Undisclosed** Mar 2010

An exit counts when it came after the firm's first round in the company. From historical deal records.

## The cheque

Series A Series B Series C

Median round joined **$16M** the round, not its cheque

Led 0 of 42 rounds **0%**

- **Sole investor:** Never alone
- **Last cheque:** Aug 2016
- **Exits:** 6 from the portfolio

Rounds by stage said on their site

- Series A *12*
- Series B *8*
- Series C *7*
- Venture *6*
- Growth *4*
- Series D *3*

Cheques by year Led Joined

2007 2016

Often in the room with

- [Domain Associates](https://millionrounds.com/fund/domain-associates) 10
- [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) 7
- [Asset Management Ventures](https://millionrounds.com/fund/asset-management-ventures) 5
- [Canaan](https://millionrounds.com/fund/canaan-partners) 5
- [Kleiner Perkins Caufield & Byers](https://millionrounds.com/fund/kleiner-perkins-caufield-and-byers) 5
- [Mohr Davidow Ventures](https://millionrounds.com/fund/mohr-davidow-ventures) 4

**Pitching Pappas Ventures?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as Pappas Ventures. A count of rooms they were both in, not a relationship either has claimed.

[**Domain Associates** VC firm **10** rounds together](https://millionrounds.com/fund/domain-associates)[**New Enterprise Associates** VC firm **7** rounds together](https://millionrounds.com/fund/new-enterprise-associates)[**Asset Management Ventures** VC firm **5** rounds together](https://millionrounds.com/fund/asset-management-ventures)[**Canaan** VC firm **5** rounds together](https://millionrounds.com/fund/canaan-partners)[**Kleiner Perkins Caufield & Byers** VC firm **5** rounds together](https://millionrounds.com/fund/kleiner-perkins-caufield-and-byers)[**Mohr Davidow Ventures** VC firm **4** rounds together](https://millionrounds.com/fund/mohr-davidow-ventures)[**Morningside Group** VC firm **4** rounds together](https://millionrounds.com/fund/morningside)[**Alta Partners** VC firm **3** rounds together](https://millionrounds.com/fund/alta-partners)[**Care Capital** Growth equity **3** rounds together](https://millionrounds.com/fund/care-capital)[**EQT life science** Private equity **3** rounds together](https://millionrounds.com/fund/lsp-bioventures)[**Fonds de solidarite Ftq** VC firm **3** rounds together](https://millionrounds.com/fund/fonds-de-solidarite-ftq)[**Frazier Healthcare Partners** Private equity **3** rounds together](https://millionrounds.com/fund/frazier-healthcare-partners)

## Quick answers about Pappas Ventures

### What does Pappas Ventures invest in?

Pappas Ventures invests most often at Series A and Series B (50% of the rounds on record), in sectors such as B2B, Stock Exchanges and Life Science.

### How active is Pappas Ventures?

42 investments on record, 0 of them in the last 12 months. The most recent was in Aug 2016.

### What has Pappas Ventures invested in recently?

Its most recent investments on record: Rotation Medical (Series B, Aug 2016) and AgTech Accelerator (Feb 2016).

### How big are Pappas Ventures's cheques?

The median round it joins is $16M.

### Does Pappas Ventures lead rounds?

Rarely, if at all: none of its 42 investments on record names it as the lead.

### Where does Pappas Ventures invest?

Most of the companies it backs are in the United States (90%) and Canada (10%).

### Is Pappas Ventures investing now?

No investments in the last 12 months; the latest was in Aug 2016.

### Who does Pappas Ventures invest alongside?

Most often Domain Associates (10 rounds together), New Enterprise Associates (7 rounds together) and Asset Management Ventures (5 rounds together).

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=pappas-ventures) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=pappas-ventures)